Yasuo Kitajima Selected Research

Acantholysis

1/2013	New insights into desmosome regulation and pemphigus blistering as a desmosome-remodeling disease.
8/2007	No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes.
6/2007	Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
5/2007	Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens.
11/2006	Pathogenic monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK phosphorylation in human squamous carcinoma cell line.
3/2004	Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists.
1/2004	Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes.
3/2003	Keratinocyte acetylcholine receptors regulate cell adhesion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuo Kitajima Research Topics

Disease

18	Pemphigus (Pemphigus Vulgaris) 12/2014 - 04/2003
8	Acantholysis 01/2013 - 03/2003
7	Bullous Pemphigoid (Pemphigoid) 02/2017 - 05/2004
4	Blister (Bulla) 06/2013 - 05/2004
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2008 - 11/2006
3	Skin Diseases (Skin Disease) 06/2014 - 03/2013
2	Neoplasms (Cancer) 01/2021 - 09/2002
2	Muscular Atrophy (Muscle Atrophy) 01/2021 - 01/2020
2	Muscular Dystrophies (Muscular Dystrophy) 01/2021 - 01/2020
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018 - 01/2018
2	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 09/2011 - 09/2008
2	Inflammation (Inflammations) 04/2009 - 10/2007
2	Autoimmune Diseases (Autoimmune Disease) 10/2007 - 01/2004
2	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 09/2003 - 03/2002
1	Cachexia 01/2021
1	Muscle Weakness 01/2021
1	Sarcopenia 01/2021
1	Atrophy 09/2020
1	Giant Cell Granuloma (Peripheral Giant Cell Granuloma) 10/2019
1	Diabetes Mellitus 10/2019
1	Sarcoma (Soft Tissue Sarcoma) 07/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Disease Progression 01/2018
1	Neuroinflammatory Diseases 01/2018
1	Hypertrophy 01/2018
1	Gliosis 01/2018
1	Infections 08/2015
1	Human Influenza (Influenza) 08/2015
1	Muscular Diseases (Myopathy) 12/2014
1	Erythema 06/2013
1	Exanthema (Rash) 02/2012
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 06/2011
1	Hypoglycemia (Reactive Hypoglycemia) 11/2008
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2008
1	Pemphigoid Gestationis (Herpes Gestationis) 09/2007
1	Myocardial Infarction 06/2005
1	Body Weight (Weight, Body) 03/2004

Drug/Important Bio-Agent (IBA)

17	Immunoglobulin G (IgG)IBA 06/2016 - 01/2004
11	AutoantibodiesIBA 06/2014 - 01/2004
6	AntibodiesIBA 12/2014 - 05/2004
6	AntigensIBA 03/2013 - 05/2007
5	Desmoglein 3IBA 06/2014 - 12/2005
5	DesmogleinsIBA 04/2009 - 11/2006
4	Intravenous Immunoglobulins (IVIG)FDA Link 02/2017 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 03/2013 - 09/2002
3	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2020 - 12/2014
3	p38 Mitogen-Activated Protein KinasesIBA 01/2018 - 06/2005
3	SteroidsIBA 02/2017 - 05/2004
3	Collagen Type XVIIIBA 06/2016 - 04/2009
3	Collagen Type VIIIBA 09/2011 - 09/2008
3	Prednisolone (Predate)FDA LinkGeneric 01/2011 - 05/2004
3	Keratins (Keratin)IBA 09/2003 - 03/2002
2	Dapsone FDA Link 10/2019 - 05/2004
2	CytokinesIBA 08/2015 - 10/2007
2	Desmoglein 1IBA 06/2014 - 10/2007
2	Complement System Proteins (Complement)IBA 06/2013 - 03/2013
2	EnzymesIBA 04/2009 - 09/2007
2	ImmunosorbentsIBA 04/2009 - 09/2007
2	Methylprednisolone FDA LinkGeneric 09/2008 - 01/2004
2	Plasminogen Activators (Plasminogen Activator)IBA 08/2007 - 07/2003
2	Monoclonal AntibodiesIBA 06/2007 - 11/2006
1	UbiquitinIBA 09/2020
1	DysferlinIBA 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2019
1	Amino Acids FDA Link 07/2019
1	Bone Morphogenetic Protein 4IBA 01/2018
1	CardiotoxinsIBA 01/2018
1	Chondroitin Sulfate ProteoglycansIBA 01/2018
1	camostatIBA 08/2015
1	Hemagglutinins (Hemagglutinin)IBA 08/2015
1	Peptide Hydrolases (Proteases)FDA Link 08/2015
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 08/2015
1	Serine Proteases (Serine Protease)IBA 08/2015
1	ElementsIBA 06/2014
1	Antinuclear AntibodiesIBA 02/2012
1	Antigen-Antibody Complex (Immune Complex)IBA 04/2009
1	Insulin ReceptorIBA 11/2008
1	Immunoglobulins (Immunoglobulin)IBA 09/2008
1	Delta CateninIBA 06/2008
1	gamma Catenin (Plakoglobin)IBA 06/2008
1	Desmosomal CadherinsIBA 10/2007
1	Surface Antigens (Surface Antigen)IBA 10/2007
1	ChemokinesIBA 10/2007
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2007
1	Glycoproteins (Glycoprotein)IBA 11/2006
1	DesmocollinsIBA 12/2005
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2005
1	Platelet-Derived Growth FactorIBA 06/2005
1	platelet-derived growth factor AIBA 06/2005
1	Becaplermin (PDGF-BB)FDA Link 06/2005
1	MitogensIBA 06/2005
1	Crystallins (Crystallin)IBA 06/2005
1	Carbachol (Carbastat)FDA Link 03/2004
1	Cholinergic AgonistsIBA 03/2004
1	Keratin-5 (Keratin 5)IBA 09/2003
1	Codon (Codons)IBA 09/2003

Therapy/Procedure

6	Therapeutics 01/2021 - 04/2003
2	Plasmapheresis 01/2011 - 09/2008
1	Castration 01/2021
1	Intraperitoneal Injections 06/2007